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Abstract

This study presents the development of a simple high-performance thin layer chromatography
(HPTLC) method for the determination of nicotine and its metabolite cotinine in human plasma
and urine.
The following mobile phases: methanol: ammonia (100:1.5, v:v), chloroform: acetone:
ammonia (48.75: 48.75: 2.5, v:v:v), methanol: chloroform: ammonia (48.75: 48.75: 0.5, v:v:v)
and glass plates precoated with silicagel 60 F254 (20x20) as a stationary phase were used.
Densitometric scanning was performed at 263 nm. Two different extraction procedures have been
applied: liquid-liquid extraction using dichloromethane at alkaline pH and solid-phase extraction
using C18 cartridges.
Preliminary tests in order to establish the system of solvents for development, as well as the
range of linearity, were conducted. The best separation of nicotine and cotinine was obtained by
using methanol: chloroform: ammonia (48.75: 48.75: 0.5, v:v:v) as the mobile phase. The liquidliquid extraction technique led to better results than solid phase extraction. The regression curves
were linear (with a corresponding correlation coefficient higher than 0.99) in the quantities range
of 200 ng–1000 ng/spot for both nicotine and cotinine. The UV spectra confirm the identification
of nicotine and cotinine both in the standards and in the extracts after liquid-liquid extraction.
The proposed method can be applied for the simultaneous evaluation of nicotine and cotinine
in biological samples at toxic/lethal levels. Thus, the method may be applicable in lethal nicotine
intoxication cases in forensic toxicological analysis.
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of quantities 200 – 1000 ng/spot, the calibration curves being linear.
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Introduction

Methodology

According to the recent literature, acute poisonings,
mainly in infants and children, caused by nicotine
products used as substitutes in the treatment of smoking
(such as chewable gums, transdermal nicotine patch
etc.) or other tobacco products, are commonly reported
to poison control centers (1-3).
The vast majority (90%) of these accidental
intoxications involve children up to 6 years of age (4, 5).
In the US, most such intoxications are reported with
products that looks similar to Tic-Tac candy and contain
appetizing flavors for young children. A total of 13,705
cases of ingestion of cigarettes and nicotine products
were reported in 2010, of which 70% involved children
under 1 year of age (6, 7).
Cotinine is the main metabolite of nicotine, having
a long half-life of elimination, and which can be
determined in various biological fluids for up to a few
days after exposure to tobacco smoke (8). Cotinine from
serum, saliva, or urine has now been recognized as a
specific, highly sensitive, and reliable general biomarker
for human exposure to tobacco smoke or substitution
products containing nicotine (gummy gums,
transdermal patches, etc.) (9, 10).
Considering the research literature on nicotine
poisoning, we conducted a study by HPTLC on the
identification and semi-quantitative determination of
nicotine and cotinine from biological material (plasma
and urine). In this study we evaluated the possibility of
applying the methods developed in cases of acute
nicotine intoxication.

Preparation of the solution.
We prepared standard stock solutions of 0.1%
nicotine and 0.15% cotinine, in methanol.
Procedures of extractions from plasma and urine
Liquid-liquid extraction: the spiked sample (1 mL)
has been alkalized with KOH 1M, then extracted by
vortex agitation with 5 mL of dichloromethane. After
extraction, the samples were centrifuged at 4000 rpm,
24°C, for ten minutes; the organic solvent layer was
separated and dry-evaporated, in nitrogen flow, at 40°C.
The residue was taken with 1 mL methanol.
Solid phase extraction: the spiked sample (1 mL)
was alkalized with KOH 1M. The cartridge was washed
with a mixture of methanol / sodium hydroxide solution
20%, then the sample was slowly passed over the solid
phase thus conditioned. Subsequently, the analytes were
eluted with 1 mL of methanol, the solution was dryevaporated in nitrogen flow, at 40°C and the residue was
taken with 0.5 mL methanol.
Working procedure
We have planned to spot the solutions to be
analyzed, containing the order of setting the solutions on
the plate and the volumes which are to be spotted for
each migration track (Table 1).
Table 1. Spotting plan for the semi quantitative
assay of nicotine and cotinine in urine and plasma.
Track

Materials and Methods
Reactives: (-) Nicotine standard (Merck) min.99%,
(S) (-) Cotinine standard (Sigma-Aldrich) min. 98%,
Methanol Chromosolv for HPLC (Merck), Chloroform,
Acetone, Dicloromethane, Ammonia (analytical grade).
Apparatus: Cooling centrifuge 2-15 K (Sigma),
solid phase extraction system (Visiprep Manifold
model, Supelco), evaporator under nitrogen stream
(Techne Dry-Block DB-3D model, Bibby Scientífic
Inc.), Hamilton 100 µL micro-syringe, chromatographic
development chambers, Camag Linomat 5 semiautomated spotting system, Camag TLC Scanner 3
system of processing the chromatoplates, fitted with a
dark camera, UV lamps and connected to a computer
(WinCATS software ver. 1.4.4.)
Biologic material used for the preparation of the
spiked samples: human plasma obtained from peripheral
venous blood and urine (from healthy volunteers).

1-5

No.

Nicotine/
Cotinine

Sample

Volume
(µL)

5

10 15 20

25

6

7-15

Blank
urine/plasma

Urine/
plasma
extract*

5

5

15

25

*triplicate
According to the plan of obtaining the chromateplate, the solutions to be analysed were spotted in lines,
using the semi-automatic system Linomat 5 (Camag), by
means of the Hamilton micro syringe, in nitrogen flow.
The plates were developed in the vertical chamber
(the technique has been the ascending one), previously
saturated with the vapours of the mobile phase.
After the development, the plates were evaluated
using the TLC scanner 3 (Camag), at 263 nm.
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Results
HPTLC analysis of the nicotine and cotinine, after
being extracted from urine.
We conducted a series of tests to select the optimal
developing solvent system and to establish the standard
curves, using standard solutions, as well as checking the
extraction from biological material.
Thus, we performed the standard curve in the
quantities range of 200 ng - 1000 ng/spot (200 ng - 400
ng - 600 ng - 800 ng - 1000 ng/spot); the extraction of
urine samples was performed by the liquid–liquid
procedure at pH alkaline, using dichloromethane as the
extraction solvent. We verified the extraction of nicotine
and cotinine from the urine at three levels of the
calibration curve: 200 ng/spot, 800 ng/spot and 1000
ng/spot. We worked in triplicate for each level in the
calibration curve.
In the solvent system used as the developer,
methanol: ammonia (100: 1.5), nicotine and cotinine
were characterized by Rf values of 0.795 ± 0.00522 and
0.83 ± 0.0094, respectively, according to the data
generated in the software report. Therefore, the
developing system methanol: ammonia (100: 1.5) is not
suitable for the separation of nicotine and its metabolite
cotinine. By using the mobile phase chloroform:
acetone: ammonia (48,75: 48,75: 2,5), the Rf values
decrease significantly (Rf nicotine = 0.2740 ±0.00522,
and Rfcotinine = 0.3430 ±0.00421), but no proper
separation was obtained (Figure 1).

For the quantity range of 200 ng – 1000 ng/spot, the
calibration curves with a corresponding correlation
coefficient of over 0.99 were obtained. As seen in the
regression curves, we have obtained linear regressions
with correlation coefficients higher than 0.99 in the case
of using the area, but not the height of the chromatogram
peak (Table 2). The calibration curves for nicotine and
cotinine are presented in the Figure 2.
Table 2. Parameters of the regression curves obtained in
the semi-quantitative analysis of the nicotine and cotinine
in urine

Size taken
into account

Area of the
peak
(nicotine)

Average
Equation
standard
Correlation
of the
deviation of the
coefficient
regression
points towards
(r)
line
the regression
line
Y=2866
+
14.57*X

0.99488

4.65 %

Y=128.5 +
0.3193*X

0.97856

7.67 %

Area of the
peak
(cotinine)

Y=7257+
24.67*X

0.99054

5.66 %

Height of
the peak
(cotinine)

Y=243.2
+
0.3126*X

0.95993

7.73 %

Height of
the peak
(nicotine)

Figure 2. The calibration curves for nicotine (a) and
cotinine (b) in the range of 200 – 1000 ng/mL

Figure 1. The chromatogram obtained at the
evaluation of nicotine and cotinine in the urine
using HPTLC [liquid-liquid extraction; a) 3D
chromatogram; b) Integrated peak for the
nicotine and cotinine extracted from urine]
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UV spectra corresponding to the peaks separated at
Rf values approximately 0.27 and 0.34 confirm the
presence of the nicotine (Figure 3-a.) and cotinine
(Figure 3-b.) both in the standard solution and in the
extracts.

Figure 3. The UV spectra of nicotine (a.) and
cotinine (b.) standard solution and after being
extracted from the urine corresponding to the
spots separated by HPTLC
The accuracy of the method, evaluated as
percentage of recovery after extraction was determined
(Table 3), with results indicating an overestimation of
the percent of recovery, mainly at low quantities.
Table 3. The accuracy (as percentage of
recovery after extraction) of HPTLC method
for the determination of nicotine and cotinine in
urine
Quantity (ng/spot)
Average
recovery
percentage (%)
Standard deviation

200

800

Figure 4. The chromatogram obtained at the
evaluation of the nicotine and cotinine in the urine
using HPTLC (solid-phase extraction; a. 3D
chromatogram; b. Integrated peak for the nicotine
and cotinine extracted from plasma)
We also established the calibration curves using
five quantity levels of nicotine and cotinine in the range
of 200 – 1000 ng/mL. The experimental data fit the
model of linear equations y = A + Bx well, by using only
the area of the peak as a size of quantification (Table 4).
Table 4. Parameters of the regression curves
obtained in the semi-quantitative analysis of the
nicotine and cotinine in plasma

1000
Size taken into
account

131.91

101.20

110

1.21

1.85

1.57

HPTLC analysis of the nicotine and cotinine, after
being extracted from plasma

The equation
of the
regression
line

Average
standard
Correlation deviation of the
coefficient points towards
(r)
the regression
line

Area of the peak
(nicotine)

Y=1892.133
+ 15.61*X

0.99610

2.46 %

Area of the peak
(cotinine)

Y=3345 +
14.42*X

0.99265

5.35%

The best separation of nicotine and cotinine was
In experiments on plasma samples, we applied the
achieved by using a mobile phase consisting of solid-phase extraction procedure. The results indicate
methanol: chloroform: ammonia (48.75: 48.75: 0.5). that the solid-phase extraction procedure is not suitable
The Rf values for nicotine and cotinine were 0.45±0.01 for the extraction of nicotine and cotinine from the
plasma (Figure 4-a).
and 0.34±0.01 respectively (Figure 4).
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Discussions
This paper aimed to develop a simple, efficient, and
inexpensive analytical method for evaluating nicotine
and its metabolite cotinine in biological samples (plasma
and urine). Thus, the analytical toxicology study on
nicotine and cotinine proposed in this paper supports
efforts to improve the methods of analysis for
substances frequently reported in intoxications, having
in view that toxicology laboratories require new, faster,
more sensitive, and less costly methods.
Thin layer chromatography (TLC) draws the
attention as a basic analytic method due to its simplicity,
robustness, low cost, and selectivity of detection, by
using various procedures of tracking. It is the most
efficient method for low cost analyses of a large number
of tests, especially for screening the abuse substances
present in biological fluids and tissues (11).
The research conducted herein has taken into
consideration the fact that over time many methods have
been developed for the determination of nicotine and its
cotinine metabolite from biological fluids, but most
involve either toxic solvents (such as benzene) or
complex equipment such as HPLC, mass spectrometer,
etc. The extraction methods reported in the literature
imply either solid phase extraction on an octadecylsilane
(C18) cartridge or different liquid-liquid extraction
techniques (12, 13). Most TLC methods for nicotine
determination have been developed for evaluation in
tobacco extracts or tobacco products (14, 15). Generally,
there are few TLC methods for evaluating nicotine along
with its metabolite cotinine in biological samples.
Based on data in the literature regarding the analysis
of nicotine by TLC, we have done a series of preliminary
tests in order to establish the system of solvents for
separating nicotine from its metabolite, as well as the
range of linearity. As part of these tests, we checked the
extraction from urine and plasma samples, by testing
comparatively two extraction methods: a liquid-liquid
method, using dichloromethane as solvent, and a solidphase extraction method using C18 cartridge. These
experimental explorations, correlated with the
evaluation of the data reported in the literature, have
shown that the liquid-liquid extraction is more
advantageous. Spectra of the nicotine and cotinine peaks
in standard solutions and urine extracts as well as peak
purity of extracted substances show that the extraction
procedure used is appropriate, as the peak is pure.
However, at very low concentrations, there is a tendency
to overestimate the yields of extraction. The solid-phase
extraction method, although shorter regarding analysis

time, is not appropriate, because neither nicotine nor its
metabolite could be extracted from plasma (16).
We have also assessed several systems of solvents
as a mobile phase (methanol: ammonia 100:1.5;
chloroform: acetone: ammonia 48.75:48.75:2.5;
chloroform: methanol: ammonia 48.75:48.75:0.5), on
the basis of which we have selected the system
chloroform: methanol: ammonia 48.75:48.75:0.5, as the
best for the separation of the nicotine from cotinine. By
using the first solvent system (methanol: ammonia
100:1.5), the Rf values are high (around of 0.80) and the
nicotine does not separate from cotinine. The reduction
of the solvent polarity with the second solvent system
chloroform: acetone: ammonia (48.75:48.75:2.5)
resulted in decreased Rf values (0.27 for nicotine and
0.34 for cotinine), but good separation was not obtained.
Changing the composition of the solvent system by
replacing acetone with methanol, more polar solvent and
reducing the amount of alkalizing agent provided the
best separation of nicotine from cotinine (Rf values of
0.45 and 0.34, respectively). The Rf values fall within
the acceptability condition on the deviation of ± 5% (16,
17, 18).
WinCATS software carries out the quantitative
analysis of the chromatograms obtained through TLC.
This procedure provides calibration graphics which
represent the height of the peak or its integrated area
according to the quantity of spotted substance. The
experimental results indicate that, for the quantity range
of 200 ng – 1000 ng/spot, the calibration plots with a
good linear relationship (correlation coefficient over
0.99) have been obtained both for nicotine and cotinine
by using the area of the peak as a measure of
quantification (19).

Conclusions
We have established the experimental conditions
for the identification through HPTLC of the nicotine in
presence of its main metabolite, cotinine, in samples of
plasma and urine. Thus, we have done the analysis of the
nicotine and its metabolite cotinine, using pre-coated
glass plates (silicagel 60 F 254), the mobile phase
chloroform: methanol: ammonia 48.75:48.75:0.5, and
detection at 263 nm. The positive identification has been
confirmed by the similarity of the UV spectra of the
extracted substances, with those of the standard
solutions.
The method allowed the semi-quantitative
evaluation of nicotine and cotinine in the range of
quantities 200 – 1000 ng/spot, the calibration curves
being linear.
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